Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    flydubai adds Aktau, Atyrau and Tyumen to winter network

    November 21, 2026

    UK and EU agree digital partnership at Brussels summit

    November 21, 2026

    Russian researchers develop heat resistant alloy for flights

    November 20, 2026
    Irish MonitorIrish Monitor
    • Automotive

      Austria electric car registrations jump 63% in October

      November 14, 2026

      Jaguar Type 01 electric GT debuts with 1,030 PS

      October 7, 2026

      German automaker Porsche extends site guarantees until 2035

      July 28, 2026

      FIA renews push for V8 engines in Formula 1

      July 4, 2026

      Electric car discounts narrow in German market

      May 30, 2026
    • Business

      Euro area annual inflation rises in October as energy jumps

      November 20, 2026

      European gas prices fall 4% to $998 per 1,000 cubic metres

      November 18, 2026

      Gold hovers near one-year low as firm dollar weighs

      November 18, 2026

      Russia’s IT small business sector grows 15% to 256,000 firms

      November 17, 2026

      Italy fines Meta €805 million over Facebook photo access

      November 16, 2026
    • Entertainment

      Generative AI in entertainment advances beyond Affleck’s view

      January 27, 2026

      Apple Arcade adds Jeopardy and NFL games in September update

      August 19, 2025

      Disney and Marvel’s R-rated film hits billion-dollar milestone

      August 17, 2024

      Web3 leader Immutable rolls out $50M gaming rewards initiative

      April 27, 2024

      USHER’s pre-Super Bowl experience on Apple Music

      February 7, 2024
    • Health

      WHO says ending cholera by 2030 is within reach

      November 12, 2026

      Global Impact of 2026 Nobel Medicine Award Highlights Optogenetics Breakthrough

      October 6, 2026

      Global Study from UAE Links Environment and Lifestyle to Accelerated Biological Aging

      October 3, 2026

      WHO Issues Global Heat Risk Guidelines for Mass Gatherings to Safeguard Public Health

      October 2, 2026

      Natural Compound from Pomegranates Shows Promise for Heart Health in UK Research

      October 1, 2026
    • Lifestyle

      Adidas launches You Got This campaign on sideline support

      March 3, 2026

      JP Morgan funds Fresha with $31 million for AI and robotics growth

      August 23, 2024

      Adidas, Highsnobiety debut limited-edition sneakers

      January 6, 2024

      Unraveling Starbucks’ phenomenon as a worldwide coffee powerhouse

      September 1, 2023

      How Nike’s Kobe 8 Protro Halo Marks an Emotional Milestone

      August 29, 2023
    • Luxury

      Price hikes and lack of innovation erode luxury market confidence

      November 18, 2024

      Uncover the allure of Rolex Deepsea – luxury awaits.

      April 10, 2024

      Beyond timekeeping to the prestige of the Rolex Day-Date

      March 2, 2024

      Rare uncut emerald dazzles at Sharjah show

      February 1, 2024

      Porsche and Frauscher launch the electric 850 Fantom Air

      October 17, 2023
    • News

      UK and EU agree digital partnership at Brussels summit

      November 21, 2026

      European Commission confirms AI-driven cyberattack

      November 20, 2026

      EU tells Andy Burnham no deals unless UK joins single market

      November 19, 2026

      Milburn review seeks reset to get 440,000 young people into work

      November 17, 2026

      EU and Nigeria sign agreement to speed up migrant returns

      November 12, 2026
    • Sports

      IOC and CAS rulings open path for Russia’s sporting return

      November 9, 2026

      Spain knock Portugal out of FIFA World Cup

      July 7, 2026

      Haaland double sends Norway past Brazil in World Cup

      July 6, 2026

      Egypt advance after shootout win over Australia

      July 4, 2026

      Spain advances after 3-0 World Cup win over Austria

      July 3, 2026
    • Technology

      Russian researchers develop heat resistant alloy for flights

      November 20, 2026

      EU launches €525 million platform for chip design start-ups

      November 6, 2026

      Putin allows temporary use of foreign data centres

      November 3, 2026

      Apple iPhone Duo redefines foldables with passport design

      November 2, 2026

      Apple brings OLED and Touch to new MacBook Pro

      October 29, 2026
    • Travel

      flydubai adds Aktau, Atyrau and Tyumen to winter network

      November 21, 2026

      flydubai adds winter flights to Riga, Salzburg and Vilnius

      November 11, 2026

      European Union Sees 1.321 Billion Tourist Nights in Early 2026 Period

      September 3, 2026

      Russia’s International Tourism Gains Momentum Across Major Regions in Early 2026

      September 2, 2026

      Shropshire Extends Free Weekday Bus Travel to Disabled Pass Holders Across the Entire Region

      August 22, 2026
    Irish MonitorIrish Monitor
    Home » Heart failure studies revisit digoxin after trial data
    Health

    Heart failure studies revisit digoxin after trial data

    May 23, 2026
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    GRONINGEN, NETHERLANDS / EuroWire / — Low dose digoxin, a medicine derived from digitalis and used in cardiology for more than two centuries, has returned to the center of heart failure research after new Dutch and international studies reported fewer worsening heart failure events among patients receiving digitalis glycosides. The findings focus on patients with heart failure with reduced or mildly reduced ejection fraction, a group at elevated risk of hospital treatment, urgent care visits and cardiovascular death.

    Heart failure studies revisit digoxin after trial data
    Digoxin data highlights the role of older medicines in contemporary heart failure care.

    The DECISION trial, led by University Medical Center Groningen cardiologists, enrolled 1,001 patients with symptomatic chronic heart failure at 43 sites in the Netherlands. Participants had a left ventricular ejection fraction of 50 percent or lower and were randomly assigned to receive low dose digoxin or placebo in addition to standard care. The trial used blood monitoring to target serum digoxin concentrations of 0.5 to 0.9 nanograms per milliliter.

    In DECISION, the primary composite endpoint included total worsening heart failure events and cardiovascular mortality. The trial recorded fewer events in the digoxin group than in the placebo group, but the result did not reach statistical significance. Cardiovascular mortality was similar between groups. The study population had a mean age of about 72 years, included women and men, and included patients with atrial fibrillation as well as sinus rhythm.

    Combined evidence strengthens findings

    A separate meta analysis published in JAMA combined data from three large placebo controlled trials of digitalis glycosides involving 9,013 participants. The pooled analysis found digitalis glycoside treatment was associated with a lower risk of cardiovascular death or first worsening heart failure event, mainly because of fewer worsening heart failure events. The analysis did not show a reduction in all cause mortality or cardiovascular death when those outcomes were assessed separately.

    The University Medical Center Groningen researchers also highlighted the cost of digoxin, which is widely available as a generic medicine and can cost less than 10 cents per day in some settings. That price has drawn attention because heart failure care commonly involves multiple medicines taken long term. The studies assessed digoxin as an add on therapy rather than as a replacement for established guideline directed treatments.

    Safety findings define current evidence

    The European Society of Cardiology presented the findings at Heart Failure 2026, where researchers discussed the DECISION trial, the pooled analysis and related evidence on digitalis glycosides. Low dose digoxin was generally well tolerated in DECISION under monitored serum concentration targets. The trial also included analyses of treatment discontinuation, which recorded more cardiovascular death or worsening heart failure events after withdrawal of digoxin than after withdrawal of placebo.

    The evidence places an inexpensive older medicine back into contemporary heart failure debate while preserving important limits from the data. DECISION did not meet statistical significance for its primary endpoint, and the larger pooled evidence showed benefit driven by fewer worsening heart failure events rather than by lower mortality. The findings describe measurable outcomes in defined patient groups, supported by randomized trial data, dosing controls and modern background heart failure therapy.

    Related Posts

    Austria electric car registrations jump 63% in October

    November 14, 2026

    WHO says ending cholera by 2030 is within reach

    November 12, 2026

    IOC and CAS rulings open path for Russia’s sporting return

    November 9, 2026

    MENA Newswire Expands Network with Eurasian Newswire

    October 15, 2026

    Global Impact of 2026 Nobel Medicine Award Highlights Optogenetics Breakthrough

    October 6, 2026

    Global Study from UAE Links Environment and Lifestyle to Accelerated Biological Aging

    October 3, 2026
    Editor's Pick

    flydubai adds Aktau, Atyrau and Tyumen to winter network

    November 21, 2026

    UK and EU agree digital partnership at Brussels summit

    November 21, 2026

    Russian researchers develop heat resistant alloy for flights

    November 20, 2026

    European Commission confirms AI-driven cyberattack

    November 20, 2026

    Euro area annual inflation rises in October as energy jumps

    November 20, 2026

    EU tells Andy Burnham no deals unless UK joins single market

    November 19, 2026

    European gas prices fall 4% to $998 per 1,000 cubic metres

    November 18, 2026

    Gold hovers near one-year low as firm dollar weighs

    November 18, 2026
    © 2024 Irish Monitor | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.